An malaria caused by infection with Plasmodium ovale.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
The limited documentation surrounding Plasmodium ovale malaria reflects the challenges of studying diseases that affect fewer populations. This condition is less common than other malaria types, leading to fewer systematic clinical studies. Additionally, the clinical features may overlap with those of other malaria species, complicating characterization efforts.
To navigate your care for Plasmodium ovale malaria, consider consulting with an infectious disease specialist who has experience in treating malaria. Additionally, while there are no specific patient organizations identified for this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may provide valuable insights. Staying informed about treatment options and potential clinical trials is crucial, so regularly check ClinicalTrials.gov for updates. Engaging with healthcare providers who are knowledgeable about malaria can also help in understanding your condition better.
There are several orphan drugs designated for the treatment of Plasmodium ovale malaria, including artesunate, quinine sulfate, and tafenoquine. In addition, multiple drugs are in development, such as (R)-N2-(4-cyclopropyl-5-fluoro-6-methylpyridin-2-yl)-N4-(1, 5-dimethyl-1H-pyrazol-3-yl)-5-(3,4-dimethylpiperazin-1-yl)pyrimidine-2,4-diamine and others. Currently, no active clinical trials are available, but you can monitor ongoing research through ClinicalTrials.gov for updates on potential studies. [ClinicalTrials.gov](https://clinicaltrials.gov)
Actionable guidance for navigating care for Plasmodium ovale malaria
To navigate your care for Plasmodium ovale malaria, consider consulting with an infectious disease specialist who has experience in treating malaria. Additionally, while there are no specific patient organizations identified for this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may provide valuable insights. Staying informed about treatment options and potential clinical trials is crucial, so regularly check ClinicalTrials.gov for updates. Engaging with healthcare providers who are knowledgeable about malaria can also help in understanding your condition better.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.